Evidence Synthesis for Decision Making 5: The Baseline Natural History Model

被引:59
作者
Dias, Sofia [1 ]
Welton, Nicky J. [1 ]
Sutton, Alex J. [2 ]
Ades, A. E. [1 ]
机构
[1] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England
[2] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England
关键词
cost-effectiveness analysis; Bayesian meta-analysis; multiparameter evidence synthesis; RANDOM-EFFECTS METAANALYSIS; COST-EFFECTIVENESS; TRANSITION-PROBABILITIES; MULTIPARAMETER SYNTHESIS; OUTCOMES; INTERVENTIONS; PREVALENCE; FRAMEWORK; EXAMPLE; CHAIN;
D O I
10.1177/0272989X13485155
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Most cost-effectiveness analyses consist of a baseline model that represents the absolute natural history under a standard treatment in a comparator set and a model for relative treatment effects. We review synthesis issues that arise on the construction of the baseline natural history model. We cover both the absolute response to treatment on the outcome measures on which comparative effectiveness is defined and the other elements of the natural history model, usually downstream of the shorter-term effects reported in trials. We recommend that the same framework be used to model the absolute effects of a standard treatment or placebo comparator as that used for synthesis of relative treatment effects and that the baseline model is constructed independently from the model for relative treatment effects, to ensure that the latter are not affected by assumptions made about the baseline. However, simultaneous modeling of baseline and treatment effects could have some advantages when evidence is very sparse or when other research or study designs give strong reasons for believing in a particular baseline model. The predictive distribution, rather than the fixed effect or random effects mean, should be used to represent the baseline to reflect the observed variation in baseline rates. Joint modeling of multiple baseline outcomes based on data from trials or combinations of trial and observational data is recommended where possible, as this is likely to make better use of available evidence, produce more robust results, and ensure that the model is internally coherent.
引用
收藏
页码:657 / 670
页数:14
相关论文
共 46 条
[1]   A chain of evidence with mixed comparisons: models for multi-parameter synthesis and consistency of evidence [J].
Ades, AE .
STATISTICS IN MEDICINE, 2003, 22 (19) :2995-3016
[2]   Multiparameter evidence synthesis in epidemiology and medical decision-making: current approaches [J].
Ades, AE ;
Sutton, AJ .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 2006, 169 :5-35
[3]  
[Anonymous], 2008, Guide to the methods of technology appraisal
[4]  
[Anonymous], 2008, Modern epidemiology
[5]  
[Anonymous], 2012, Evidence synthesis for decision making in healthcare
[6]  
Briggs A., 2008, DECISION MODELLING FOR HEALTH ECONOMIC EVALUATION
[7]  
Brown J, 2006, HEALTH ECON, V15, P435, DOI 10.1002/hec.1077
[8]  
Burch J, 2010, HEALTH TECHNOL ASSES, V13, P1
[9]  
Colbourn T, 2007, HEALTH TECHNOL ASSES, V11, pIX
[10]  
Dias S., 2016, NICE DSU Technical Support Document 4: inconsistency in networks of evidence based on randomised controlled trials